Point-Counterpoint: Muscle Invasive Bladder Cancer–Trimodal Therapy Perspective
Tyler F. Stewart, MD, assistant professor in the Department of Medicine at the University of California, San Diego, explores the topic of cystectomy versus trimodality therapy for muscle invasive bladder cancer. With a focus on the importance of multidisciplinary collaboration, he discusses the treatment strategies and considerations involved in making the best decisions for patients. A countering perspective on cystectomy is available here: https://grandroundsinurology.com/poin...

▶︎
Muscle Invasive Bladder Cancer

▶︎
UW Urology Grand Rounds: Perioperative Chemotherapy for Muscle Invasive Bladder Cancer – 9/4/2024

▶︎
CISTO: Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade NMIBC

▶︎
Biochemical Recurrence in Prostate Cancer

▶︎
Management of High Risk NMIBC—What’s New in Intravesical Therapy | Treatment of Bladder Cancer

▶︎
Bladder Removal Surgery: Preparation to Recovery

▶︎
Point-Counterpoint: Muscle Invasive Bladder Cancer–Cystectomy Perspective

▶︎
I Had No Symptoms - Margo | Bladder Cancer | The Patient Story

▶︎
Treatment of Prostate Cancer: Testosterone and PCa - From Dogma to Data

▶︎
5.26.2020 Urology COViD Didactics - Almost Everything You Wanted to Know About... Urinary Diversions

▶︎
Bladder Cancer: NON-Muscle Invasive (Superficial Bladder Cancer)

▶︎
UROwebinar: Difficult bladder cancer cases

▶︎
Treatment of Prostate Cancer: Brian J. Moran Distinguished Lecture: Prostate Brachytherapy

▶︎
Management of Non-Muscle Invasive Bladder Cancer

▶︎
New bladder cancer treatment would keep bladder intact

▶︎
Bladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?

▶︎
Can AI Replace the Prostate Biopsy? Dr. Wayne Brisbane on the Future - EP. 184

▶︎
Introduction to Beating Bladder Cancer

▶︎
Bladder Cancer 101 | Symptoms, Diagnosis & Treatment

▶︎
